Clinical Trial Update: Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized controlled trial evaluating the applicability of 3D-HDRA in patients with primary liver cancer that is resectable.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Snippet

Sponsor: Zhujiang Hospital | Conditions: Liver, Cancer of, Primary Resectable | Phase 3 | Status: UNKNOWN